Tag: MSD
NHS introduces ‘Pembrolizumab’ to treat triple-negative breast cancer
The NHS has secured a deal for ‘Pembrolizumab’ to treat women with triple-negative breast cancer.
Up to 1,600 women a year affected by high risk...
Follow us
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Company
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc